Innate immune natural killer cells and their role in HIV and SIV infection

Bibliography

• 1  Christensen JE, Thomsen AR: Co-ordinating innate and adaptive immunity to viral infection: mobility is the key. APMIS117,338–355 (2009).
  Medline CASGoogle Scholar
• 2  Gregoire C, Chasson L, Luci C et al.: The trafficking of natural killer cells. Immunol. Rev.220,169–182 (2007).
  Medline CASGoogle Scholar
• 3  Blum KS, Pabst R: Lymphocyte numbers and subsets in the human blood. Do they mirror the situation in all organs? Immunol. Lett.108,45–51 (2007).
  Medline CASGoogle Scholar
• 4  Kiessling R, Klein E, Pross H et al.: “Natural” killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell. Eur. J. Immunol.5,117–121 (1975).
  Medline CASGoogle Scholar
• 5  Kiessling R, Klein E, Wigzell H: “Natural” killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur. J. Immunol.5,112–117 (1975).
  Medline CASGoogle Scholar
• 6  Janeway CA: Natural killer cells: a primitive immune system. Nature341,108 (1989).
  Medline CASGoogle Scholar
• 7  Kim S, Poursine-Laurent J, Truscott SM et al.: Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature436,709–713 (2005).
  Medline CASGoogle Scholar
• 8  Anfossi N, Andre P, Guia S et al.: Human NK cell education by inhibitory receptors for MHC class I. Immunity25,331–342 (2006).
  Medline CASGoogle Scholar
• 9  Hayakawa Y, Screpanti V, Yagita H et al.: NK cell TRAIL eliminates immature dendritic cells in vivo and limits dendritic cell vaccination efficacy. J. Immunol.172,123–129 (2004).
  Medline CASGoogle Scholar
• 10  Piccioli D, Sbrana S, Melandri E et al.: Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells. J. Exp. Med.195,335–341 (2002).
  Medline CASGoogle Scholar
• 11  Takeda K, Dennert G: The development of autoimmunity in C57BL/6 lpr mice correlates with the disappearance of natural killer type 1-positive cells: evidence for their suppressive action on bone marrow stem cell proliferation, B cell immunoglobulin secretion, and autoimmune symptoms. J. Exp. Med.177,155–164 (1993).
  Medline CASGoogle Scholar
• 12  Lu L, Ikizawa K, Hu D et al.: Regulation of activated CD4⁺ T cells by NK cells via the Qa-1-NKG2A inhibitory pathway. Immunity26,593–604 (2007).
  Medline CASGoogle Scholar
• 13  O’Leary JG, Goodarzi M, Drayton DL et al.: T cell- and B cell-independent adaptive immunity mediated by natural killer cells. Nat. Immunol.7,507–516 (2006).
  MedlineGoogle Scholar
• 14  Sun JC, Lanier LL: Natural killer cells remember: an evolutionary bridge between innate and adaptive immunity? Eur. J. Immunol.39,2059–2064 (2009).
  Medline CASGoogle Scholar
• 15  Alter G, Malenfant JM, Delabre RM et al.: Increased natural killer cell activity in viremic HIV-1 infection. J. Immunol.173,5305–5311 (2004).
  Medline CASGoogle Scholar
• 16  O’Connor GM, Holmes A, Mulcahy F et al.: Natural killer cells from long-term non-progressor HIV patients are characterized by altered phenotype and function. Clin. Immunol.124,277–283 (2007).
  MedlineGoogle Scholar
• 17  Martin MP, Qi Y, Gao X et al.: Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat. Genet.39,733–740 (2007).
  Medline CASGoogle Scholar
• 18  Ritz J, Schmidt RE, Michon J et al.: Characterization of functional surface structures on human natural killer cells. Adv. Immunol.42,181–211 (1988).
  Medline CASGoogle Scholar
• 19  Lanier LL, Testi R, Bindl J et al.: Identity of Leu-19 (CD56) leukocyte differentiation antigen and neural cell adhesion molecule. J. Exp. Med.169,2233–2238 (1989).
  Medline CASGoogle Scholar
• 20  Cooper MA, Fehniger TA, Caligiuri MA: The biology of human natural killer-cell subsets. Trends Immunol.22,633–640 (2001).
  Medline CASGoogle Scholar
• 21  Vossen MT, Matmati M, Hertoghs KM et al.: CD27 defines phenotypically and functionally different human NK cell subsets. J. Immunol.180,3739–3745 (2008).
  Medline CASGoogle Scholar
• 22  Fehniger TA, Cooper MA, Nuovo GJ et al.: CD56^bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity. Blood101,3052–3057 (2003).
  Medline CASGoogle Scholar
• 23  Ferlazzo G, Munz C: NK cell compartments and their activation by dendritic cells. J. Immunol.172,1333–1339 (2004).
  Medline CASGoogle Scholar
• 24  Romagnani C, Juelke K, Falco M et al.: CD56^brightCD16^- killer Ig-like receptor- NK cells display longer telomeres and acquire features of CD56^dim NK cells upon activation. J. Immunol.178,4947–4955 (2007).
  Medline CASGoogle Scholar
• 25  Ferlazzo G, Thomas D, Lin SL et al.: The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic. J. Immunol.172,1455–1462 (2004).
  Medline CASGoogle Scholar
• 26  Bradley TP, Bonavida B: Mechanism of cell-mediated cytotoxicity at the single cell level. IV. Natural killing and antibody-dependent cellular cytotoxicity can be mediated by the same human effector cell as determined by the two-target conjugate assay. J. Immunol.129,2260–2265 (1982).
  Medline CASGoogle Scholar
• 27  Maghazachi AA: Role of chemokines in the biology of natural killer cells. Curr. Top. Microbiol. Immunol. (2010) (Epub ahead of print).
  MedlineGoogle Scholar
• 28  Yagel S: The developmental role of natural killer cells at the fetal-maternal interface. Am. J. Obstet. Gynecol.201,344–350 (2009).
  Medline CASGoogle Scholar
• 29  Kwak-Kim J, Park JC, Ahn HK et al.: Immunological modes of pregnancy loss. Am. J. Reprod. Immunol. (2010) (Epub ahead of print).
  Google Scholar
• 30  Redman CW, Sargent IL: Immunology of pre-eclampsia. Am. J. Reprod. Immunol. (2010) (Epub ahead of print).
  MedlineGoogle Scholar
• 31  Hanna J, Goldman-Wohl D, Hamani Y et al.: Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat. Med.12,1065–1074 (2006).
  Medline CASGoogle Scholar
• 32  Cella M, Fuchs A, Vermi W et al.: A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature457,722–725 (2009).
  Medline CASGoogle Scholar
• 33  Sanos SL, Bui VL, Mortha A et al.: RORgt and commensal microflora are required for the differentiation of mucosal interleukin 22-producing NKp46⁺ cells. Nat. Immunol.10,83–91 (2009).
  Medline CASGoogle Scholar
• 34  Luci C, Reynders A, Ivanov, II et al.: Influence of the transcription factor RORgt on the development of NKp46⁺ cell populations in gut and skin. Nat. Immunol.10,75–82 (2009).
  Medline CASGoogle Scholar
• 35  Satoh-Takayama N, Dumoutier L, Lesjean-Pottier S et al.: The natural cytotoxicity receptor NKp46 is dispensable for IL-22-mediated innate intestinal immune defense against Citrobacter rodentium. J. Immunol.183,6579–6587 (2009).
  Medline CASGoogle Scholar
• 36  Andrews DM, Smyth MJ: A potential role for RAG-1 in NK cell development revealed by analysis of NK cells during ontogeny. Immunol. Cell. Biol.88,107–116 (2010).
  Medline CASGoogle Scholar
• 37  Haraguchi K, Suzuki T, Koyama N et al.: Notch activation induces the generation of functional NK cells from human cord blood CD34-positive cells devoid of IL-15. J. Immunol.182,6168–6178 (2009).
  Medline CASGoogle Scholar
• 38  Kamizono S, Duncan GS, Seidel MG et al.: Nfil3/E4bp4 is required for the development and maturation of NK cells in vivo. J. Exp. Med.206,2977–2986 (2009).
  Medline CASGoogle Scholar
• 39  Huntington ND, Legrand N, Alves NL et al.: IL-15 trans-presentation promotes human NK cell development and differentiation in vivo. J. Exp. Med.206,25–34 (2009).
  Medline CASGoogle Scholar
• 40  Satoh-Takayama N, Lesjean-Pottier S, Vieira P et al.: IL-7 and IL-15 independently program the differentiation of intestinal CD3-NKp46⁺ cell subsets from Id2-dependent precursors. J. Exp. Med.207,273–280 (2010).
  Medline CASGoogle Scholar
• 41  Yun S, Lee SH, Kang YH et al.: YC-1 enhances natural killer cell differentiation from hematopoietic stem cells. Int. Immunopharmacol.10(4),481–486 (2010).
  Medline CASGoogle Scholar
• 42  Caligiuri MA: Human natural killer cells. Blood112,461–469 (2008).
  Medline CASGoogle Scholar
• 43  Chinen H, Matsuoka K, Sato T et al.: Lamina propria c-kit⁺ immune precursors reside in human adult intestine and differentiate into natural killer cells. Gastroenterology133,559–573 (2007).
  Medline CASGoogle Scholar
• 44  Lynch L, O’Donoghue D, Dean J et al.: Detection and characterization of hemopoietic stem cells in the adult human small intestine. J. Immunol.176,5199–5204 (2006).
  Medline CASGoogle Scholar
• 45  Cupedo T, Crellin NK, Papazian N et al.: Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC⁺ CD127⁺ natural killer-like cells. Nat. Immunol.10,66–74 (2009).
  Medline CASGoogle Scholar
• 46  Bostik P, Kobkitjaroen J, Tang W et al.: Decreased NK cell frequency and function is associated with increased risk of KIR3DL allele polymorphism in simian immunodeficiency virus-infected rhesus macaques with high viral loads. J. Immunol.182,3638–3649 (2009).
  Medline CASGoogle Scholar
• 47  Ding Y, Sumitran S, Holgersson J: Direct binding of purified HLA class I antigens by soluble NKG2/CD94 C-type lectins from natural killer cells. Scand. J. Immunol.49,459–465 (1999).
  Medline CASGoogle Scholar
• 48  Pende D, Parolini S, Pessino A et al.: Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells. J. Exp. Med.190,1505–1516 (1999).
  Medline CASGoogle Scholar
• 49  Sivori S, Vitale M, Morelli L et al.: p46, a novel natural killer cell-specific surface molecule that mediates cell activation. J. Exp. Med.186,1129–1136 (1997).
  Medline CASGoogle Scholar
• 50  Vitale M, Bottino C, Sivori S et al.: NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis. J. Exp. Med.187,2065–2072 (1998).
  Medline CASGoogle Scholar
• 51  Avril T, North SJ, Haslam SM et al.: Probing the cis interactions of the inhibitory receptor Siglec-7 with α2,8-disialylated ligands on natural killer cells and other leukocytes using glycan-specific antibodies and by analysis of α2,8-sialyltransferase gene expression. J. Leukoc. Biol.80,787–796 (2006).
  Medline CASGoogle Scholar
• 52  Betser-Cohen G, Mizrahi S, Elboim M et al.: The association of MHC class I proteins with the 2B4 receptor inhibits self-killing of human NK cells. J. Immunol.184,2761–2768 (2010).
  Medline CASGoogle Scholar
• 53  Vales-Gomez M, Reyburn HT, Erskine RA et al.: Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E. EMBO J.18,4250–4260 (1999).
  Medline CASGoogle Scholar
• 54  Bryceson YT, Ljunggren HG, Long EO: Minimal requirement for induction of natural cytotoxicity and intersection of activation signals by inhibitory receptors. Blood114,2657–2666 (2009).
  Medline CASGoogle Scholar
• 55  Ghiringhelli F, Menard C, Terme M et al.: CD4⁺CD25⁺ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-β-dependent manner. J. Exp. Med.202,1075–1085 (2005).
  Medline CASGoogle Scholar
• 56  Kawakami Y, Tomimori Y, Yumoto K et al.: Inhibition of NK cell activity by IL-17 allows vaccinia virus to induce severe skin lesions in a mouse model of eczema vaccinatum. J. Exp. Med.206,1219–1225 (2009).
  MedlineGoogle Scholar
• 57  Robson NC, Wei H, McAlpine T et al.: Activin-A attenuates several human natural killer cell functions. Blood113,3218–3225 (2009).
  Medline CASGoogle Scholar
• 58  Tarazona R, Delgado E, Guarnizo MC et al.: Human prostasomes express CD48 and interfere with NK cell function. Immunobiology (2010) (Epub ahead of print).
  MedlineGoogle Scholar
• 59  Krzewski K, Chen X, Strominger JL: WIP is essential for lytic granule polarization and NK cell cytotoxicity. Proc. Natl Acad. Sci. USA105,2568–2573 (2008).
  Medline CASGoogle Scholar
• 60  Schleinitz N, March ME, Long EO: Recruitment of activation receptors at inhibitory NK cell immune synapses. PLoS ONE3,e3278 (2008).
  MedlineGoogle Scholar
• 61  Whittaker GC, Burshtyn DN, Orr SJ et al.: Analysis of the linker for activation of T cells and the linker for activation of B cells in natural killer cells reveals a novel signaling cassette, dual usage in ITAM signaling, and influence on development of the Ly49 repertoire. Blood112,2869–2877 (2008).
  Medline CASGoogle Scholar
• 62  Li Q: NK cell assays in immunotoxicity testing. Methods Mol. Biol.598,207–219 (2010).
  Medline CASGoogle Scholar
• 63  Fultz PN, McClure HM, Anderson DC et al.: Isolation of a T-lymphotropic retrovirus from naturally infected sooty mangabey monkeys (Cercocebus atys). Proc. Natl Acad. Sci. USA83,5286–5290 (1986).
  Medline CASGoogle Scholar
• 64  Daniel MD, Letvin NL, King NW et al.: Isolation of T-cell tropic HTLV-III-like retrovirus from macaques. Science228,1201–1204 (1985).
  Medline CASGoogle Scholar
• 65  VandeWoude S, Apetrei C: Going wild: lessons from naturally occurring T-lymphotropic lentiviruses. Clin. Microbiol. Rev.19,728–762 (2006).
  Medline CASGoogle Scholar
• 66  Hahn BH, Shaw GM, De Cock KM et al.: AIDS as a zoonosis: scientific and public health implications. Science287,607–614 (2000).
  Medline CASGoogle Scholar
• 67  Webster RL, Johnson RP: Delineation of multiple subpopulations of natural killer cells in rhesus macaques. Immunology115,206–214 (2005).
  Medline CASGoogle Scholar
• 68  Reeves RK, Gillis J, Wong FE et al.: CD16^- natural killer cells: enrichment in mucosal and secondary lymphoid tissues and altered function during chronic SIV infection. Blood115(22),4439–4446 (2010).
  Medline CASGoogle Scholar
• 69  Pereira LE, Johnson RP, Ansari AA: Sooty mangabeys and rhesus macaques exhibit significant divergent natural killer cell responses during both acute and chronic phases of SIV infection. Cell. Immunol.254,10–19 (2008).
  Medline CASGoogle Scholar
• 70  Biassoni R, Fogli M, Cantoni C et al.: Molecular and functional characterization of NKG2D, NKp80, and NKG2C triggering NK cell receptors in rhesus and cynomolgus macaques: monitoring of NK cell function during simian HIV infection. J. Immunol.174,5695–5705 (2005).
  Medline CASGoogle Scholar
• 71  Rutjens E, Mazza S, Biassoni R et al.: CD8⁺ NK cells are predominant in chimpanzees, characterized by high NCR expression and cytokine production, and preserved in chronic HIV-1 infection. Eur. J. Immunol.40,1440–1450 (2010).
  Medline CASGoogle Scholar
• 72  Vivier E, Tomasello E, Baratin M et al.: Functions of natural killer cells. Nat. Immunol.9,503–510 (2008).
  Medline CASGoogle Scholar
• 73  Lanier LL: Up on the tightrope: natural killer cell activation and inhibition. Nat. Immunol.9,495–502 (2008).
  Medline CASGoogle Scholar
• 74  Bryceson YT, March ME, Ljunggren HG et al.: Activation, coactivation, and costimulation of resting human natural killer cells. Immunol. Rev.214,73–91 (2006).
  Medline CASGoogle Scholar
• 75  Brooks AG, Posch PE, Scorzelli CJ et al.: NKG2A complexed with CD94 defines a novel inhibitory natural killer cell receptor. J. Exp. Med.185,795–800 (1997).
  Medline CASGoogle Scholar
• 76  Braud VM, Allan DS, O’Callaghan CA et al.: HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature391,795–799 (1998).
  Medline CASGoogle Scholar
• 77  Steinle A, Li P, Morris DL et al.: Interactions of human NKG2D with its ligands MICA, MICB, and homologs of the mouse RAE-1 protein family. Immunogenetics53,279–287 (2001).
  Medline CASGoogle Scholar
• 78  Middleton D, Gonzelez F: The extensive polymorphism of KIR genes. Immunology129,8–19 (2010).
  Medline CASGoogle Scholar
• 79  Rajagopalan S, Long EO: A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells. J. Exp. Med.189,1093–1100 (1999).
  Medline CASGoogle Scholar
• 80  Yu J, Heller G, Chewning J et al.: Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands. J. Immunol.179,5977–5989 (2007).
  Medline CASGoogle Scholar
• 81  Tripathi P, Naik S, Agrawal S: HLA-E and immunobiology of pregnancy. Tissue Antigens67,207–213 (2006).
  Medline CASGoogle Scholar
• 82  Rebmann V, Pfeiffer K, Passler M et al.: Detection of soluble HLA-G molecules in plasma and amniotic fluid. Tissue Antigens53,14–22 (1999).
  Medline CASGoogle Scholar
• 83  Vowels BR, Gershwin ME, Gardner MB et al.: Natural killer cell activity of rhesus macaques against retrovirus-pulsed CD4⁺ target cells. AIDS Res. Hum. Retroviruses6,905–918 (1990).
  Medline CASGoogle Scholar
• 84  De Maria A, Biassoni R, Fogli M et al.: Identification, molecular cloning and functional characterization of NKp46 and NKp30 natural cytotoxicity receptors in Macaca fascicularis NK cells. Eur. J. Immunol.31,3546–3556 (2001).
  Medline CASGoogle Scholar
• 85  LaBonte ML, Hershberger KL, Korber B et al.: The KIR and CD94/NKG2 families of molecules in the rhesus monkey. Immunol. Rev.183,25–40 (2001).
  Medline CASGoogle Scholar
• 86  Mavilio D, Benjamin J, Kim D et al.: Identification of NKG2A and NKp80 as specific natural killer cell markers in rhesus and pigtailed monkeys. Blood106,1718–1725 (2005).
  Medline CASGoogle Scholar
• 87  Hershberger KL, Shyam R, Miura A et al.: Diversity of the killer cell Ig-like receptors of rhesus monkeys. J. Immunol.166,4380–4390 (2001).
  Medline CASGoogle Scholar
• 88  Hershberger KL, Kurian J, Korber BT et al.: Killer cell immunoglobulin-like receptors (KIR) of the African-origin sabaeus monkey: evidence for recombination events in the evolution of KIR. Eur. J. Immunol.35,922–935 (2005).
  Medline CASGoogle Scholar
• 89  Guethlein LA, Flodin LR, Adams EJ et al.: NK cell receptors of the orangutan (Pongo pygmaeus): a pivotal species for tracking the coevolution of killer cell Ig-like receptors with MHC-C. J. Immunol.169,220–229 (2002).
  Medline CASGoogle Scholar
• 90  Cadavid LF, Lun CM: Lineage-specific diversification of killer cell Ig-like receptors in the owl monkey, a New World primate. Immunogenetics61,27–41 (2009).
  Medline CASGoogle Scholar
• 91  Sambrook JG, Bashirova A, Palmer S et al.: Single haplotype analysis demonstrates rapid evolution of the killer immunoglobulin-like receptor (KIR) loci in primates. Genome Res.15,25–35 (2005).
  Medline CASGoogle Scholar
• 92  Bimber BN, Moreland AJ, Wiseman RW et al.: Complete characterization of killer Ig-like receptor (KIR) haplotypes in Mauritian cynomolgus macaques: novel insights into nonhuman primate KIR gene content and organization. J. Immunol.181,6301–6308 (2008).
  Medline CASGoogle Scholar
• 93  Chaichompoo P, Bostik P, Stephenson S et al.: Multiple KIR gene polymorphisms are associated with plasma viral loads in SIV infected rhesus macaques. Cell. Immuol.263(2),176–187 (2010) .
  Medline CASGoogle Scholar
• 94  Blokhuis JH, van der Wiel MK, Doxiadis GG et al.: The mosaic of KIR haplotypes in rhesus macaques. Immunogenetics62,295–306 (2010).
  MedlineGoogle Scholar
• 95  Kruse PH, Rosner C, Walter L: Characterization of rhesus macaque KIR genotypes and haplotypes. Immunogenetics62,281–293 (2010).
  MedlineGoogle Scholar
• 96  Orange JS: Human natural killer cell deficiencies. Curr. Opin. Allergy Clin. Immunol.6,399–409 (2006).
  MedlineGoogle Scholar
• 97  Mocikat R, Braumuller H, Gumy A et al.: Natural killer cells activated by MHC class I^low targets prime dendritic cells to induce protective CD8 T cell responses. Immunity19,561–569 (2003).
  Medline CASGoogle Scholar
• 98  Alter G, Altfeld M: NK cells in HIV-1 infection: evidence for their role in the control of HIV-1 infection. J. Intern. Med.265,29–42 (2009).
  Medline CASGoogle Scholar
• 99  Weber K, Meyer D, Grosse V et al.: Reconstitution of NK cell activity in HIV-1 infected individuals receiving antiretroviral therapy. Immunobiology202,172–178 (2000).
  Medline CASGoogle Scholar
• 100  Iannello A, Debbeche O, Samarani S et al.: Antiviral NK cell responses in HIV infection: II. viral strategies for evasion and lessons for immunotherapy and vaccination. J. Leukoc. Biol.84,27–49 (2008).
  Medline CASGoogle Scholar
• 101  Iannello A, Debbeche O, Samarani S et al.: Antiviral NK cell responses in HIV infection: I. NK cell receptor genes as determinants of HIV resistance and progression to AIDS. J. Leukoc. Biol.84,1–26 (2008).
  Medline CASGoogle Scholar
• 102  Bonaparte MI, Barker E: Killing of human immunodeficiency virus-infected primary T-cell blasts by autologous natural killer cells is dependent on the ability of the virus to alter the expression of major histocompatibility complex class I molecules. Blood104,2087–2094 (2004).
  Medline CASGoogle Scholar
• 103  Cohen GB, Gandhi RT, Davis DM et al.: The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity10,661–671 (1999).
  Medline CASGoogle Scholar
• 104  Brenner BG, Dascal A, Margolese RG et al.: Natural killer cell function in patients with acquired immunodeficiency syndrome and related diseases. J. Leukoc. Biol.46,75–83 (1989).
  Medline CASGoogle Scholar
• 105  Ahmad A, Menezes J: Antibody-dependent cellular cytotoxicity in HIV infections. FASEB J.10,258–266 (1996).
  Medline CASGoogle Scholar
• 106  Ullum H, Gotzsche PC, Victor J et al.: Defective natural immunity: an early manifestation of human immunodeficiency virus infection. J. Exp. Med.182,789–799 (1995).
  Medline CASGoogle Scholar
• 107  Sirianni MC, Mezzaroma I, Aiuti F et al.: Analysis of the cytolytic activity mediated by natural killer cells from acquired immunodeficiency syndrome patients in response to phytohemagglutinin or anti-CD16 monoclonal antibody. Eur. J. Immunol.24,1874–1878 (1994).
  Medline CASGoogle Scholar
• 108  Liu Q, Sun Y, Rihn S et al.: Matrix metalloprotease inhibitors restore impaired NK cell-mediated antibody-dependent cellular cytotoxicity in human immunodeficiency virus type 1 infection. J. Virol.83,8705–8712 (2009).
  Medline CASGoogle Scholar
• 109  Kottilil S, Chun TW, Moir S et al.: Innate immunity in human immunodeficiency virus infection: effect of viremia on natural killer cell function. J. Infect. Dis.187,1038–1045 (2003).
  MedlineGoogle Scholar
• 110  Mantegani P, Tambussi G, Galli L et al.: Perturbation of the natural killer cell compartment during primary human immunodeficiency virus 1 infection primarily involving the CD56^bright subset. Immunology129(2),220–233 (2009).
  MedlineGoogle Scholar
• 111  Vieillard V, Fausther-Bovendo H, Samri A et al.: Specific phenotypic and functional features of natural killer cells from HIV-infected long-term nonprogressors and HIV controllers. J. Acquir. Immune Defic. Syndr.53,564–573 (2010).
  MedlineGoogle Scholar
• 112  Hong HS, Eberhard JM, Keudel P et al.: HIV infection is associated with a preferential decline in less-differentiated CD56^dim CD16⁺ NK cells. J. Virol.84,1183–1188 (2010).
  Medline CASGoogle Scholar
• 113  Mavilio D, Benjamin J, Daucher M et al.: Natural killer cells in HIV-1 infection: dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates. Proc. Natl Acad. Sci. USA100,15011–15016 (2003).
  Medline CASGoogle Scholar
• 114  Alter G, Teigen N, Davis BT et al.: Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection. Blood106,3366–3369 (2005).
  Medline CASGoogle Scholar
• 115  De Maria A, Fogli M, Costa P et al.: The impaired NK cell cytolytic function in viremic HIV-1 infection is associated with a reduced surface expression of natural cytotoxicity receptors (NKp46, NKp30 and NKp44). Eur. J. Immunol.33,2410–2418 (2003).
  Medline CASGoogle Scholar
• 116  Boulet S, Kleyman M, Kim JY et al.: A combined genotype of KIR3DL1 high expressing alleles and HLA-B*57 is associated with a reduced risk of HIV infection. AIDS22,1487–1491 (2008).
  Medline CASGoogle Scholar
• 117  Martin MP, Gao X, Lee JH et al.: Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat. Genet.31,429–434 (2002).
  Medline CASGoogle Scholar
• 118  LaBonte ML, McKay PF, Letvin NL: Evidence of NK cell dysfunction in SIV-infected rhesus monkeys: impairment of cytokine secretion and NKG2C/C2 expression. Eur. J. Immunol.36,2424–2433 (2006).
  Medline CASGoogle Scholar
• 119  Choi EI, Reimann KA, Letvin NL: In vivo natural killer cell depletion during primary simian immunodeficiency virus infection in rhesus monkeys. J. Virol.82,6758–6761 (2008).
  Medline CASGoogle Scholar
• 120  Velilla PA, Shata MT, Lages CS et al.: Effect of low-dose IL-2 immunotherapy on frequency and phenotype of regulatory T cells and NK cells in HIV/HCV-coinfected patients. AIDS Res. Hum. Retroviruses24,52–61 (2008).
  Medline CASGoogle Scholar
• 121  Locker GJ, Kapiotis S, Veitl M et al.: Activation of endothelium by immunotherapy with interleukin-2 in patients with malignant disorders. Br. J. Haematol.105,912–919 (1999).
  Medline CASGoogle Scholar
• 122  Ponce R: Adverse consequences of immunostimulation. J. Immunotoxicol.5,33–41 (2008).
  Medline CASGoogle Scholar
• 123  Ramana Rao PV, Rajasekaran S, Raja A: Augumentation of natural killer activity with exogenous interleukins in patients with HIV and pulmonary tuberculosis coinfection. AIDS Res. Hum. Retroviruses24,1435–1443 (2008).
  MedlineGoogle Scholar
• 124  Strbo N, de Armas L, Liu H et al.: IL-21 augments natural killer effector functions in chronically HIV-infected individuals. AIDS22,1551–1560 (2008).
  Medline CASGoogle Scholar
• 125  Hall LJ, Clare S, Dougan G: NK cells influence both innate and adaptive immune responses after mucosal immunization with antigen and mucosal adjuvant. J. Immunol.184,4327–4337 (2010).
  Medline CASGoogle Scholar